Cardinal Health 2008 Annual Report Download - page 29

Download and view the complete annual report

Please find page 29 of the 2008 Cardinal Health annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 164

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164

technology products, including Alaris®intravenous medication safety and infusion therapy delivery systems,
software applications, needle-free disposables and related patient monitoring equipment and Pyxis®dispensing
systems that automate the distribution and management of medications in hospitals and other healthcare
facilities. The segment also develops, manufactures, leases and sells dispensing systems for medical supplies.
This segment provides pharmacy services to hospitals and other healthcare facilities, including full-service
department outsourcing, transitional and turn-key services for acute care hospital pharmacies, as well as remote
medication order entry and review and other services. This segment also provides clinical intelligence solutions,
including products and services that identify and prevent hospital-acquired infections and provide barcode-
enabled patient identification systems used in hospitals.
This segment primarily distributes its products direct to the customer, although it also distributes some
products through medical products distributors, including through the Healthcare Supply Chain Services—
Medical segment. This segment offers products and services principally in the United States and also in Europe,
Canada and other regions.
Medical Products and Technologies
Through its Medical Products and Technologies segment, the Company develops and manufactures medical
and surgical products for distribution to hospitals, physician offices, surgery centers and other healthcare
providers. These products include the following: infection prevention products, such as single-use surgical
drapes, gowns and apparel, exam and surgical gloves and fluid suction and collection systems; respiratory care
products, such as ventilation equipment and supplies; and medical specialties products, such as reusable surgical
instruments and biopsy needles. After acquiring the assets of Enturia Inc. (“Enturia”) during fiscal 2008, this
segment now also offers Enturia’s line of skin disinfection products sold under the ChloraPrep®brand name.
This segment primarily distributes its products through medical products distributors, including through the
Company’s Healthcare Supply Chain Services—Medical segment. It also distributes some products direct to the
customer. This segment offers products and services principally in the United States and also in Europe, Canada
and other regions.
For information on comparative segment revenue, segment profit and related financial information, see
Note 17 of “Notes to Consolidated Financial Statements,” which is incorporated herein by reference.
Changes to Reportable Segments
On July 8, 2008, the Company announced a reorganization and the consolidation of its businesses into two
primary operating and reportable segments, the Healthcare Supply Chain Services and Clinical and Medical
Products segments, to reduce costs and align resources with the needs of each segment and that, effective July 1,
2008, it would begin reporting in three reportable segments. The following indicates the changes from the fiscal
2008 reporting structure to the new reporting structure effective July 1, 2008:
Healthcare Supply Chain Services. This reportable segment will comprise all of the businesses formerly
within the Healthcare Supply Chain Services—Pharmaceutical segment other than Medicine Shoppe and will
comprise all of the businesses formerly within the Healthcare Supply Chain Services—Medical segment.
Clinical and Medical Products. This reportable segment will comprise all of the businesses formerly within
the Clinical Technologies and Services segment other than the pharmacy services business and will comprise all
of the businesses formerly within the Medical Products and Technologies segment other than the Tecomet
(orthopedic implants and instruments) and MedSystems (enteral devices and airway management products)
businesses, which were acquired by the Company through its acquisition of Viasys Healthcare Inc. (“Viasys”).
5